{"slug":"retatrutide-neuropathy","verification":{"valid":true,"entries":2,"head":"679fb555d1846bca253dd2590e2f490b3a0a4e76657e674173c27485ca1f2647"},"energy":{"passes":2,"tokens_in":15628,"tokens_out":3265,"tokens_total":18893,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"679fb555d1846bca253dd2590e2f490b3a0a4e76657e674173c27485ca1f2647"},"provenance":[{"ts":"2026-06-30T00:56:11.776Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: Retatrutide for Neuropathy\nSlug: retatrutide-neuropathy\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_focus\",\"condition\":null,\"condition_key\":null,\"primary_peptide\":null,\"peptides_in_scope\":[{\"id\":\"retatrutide\",\"name\":\"Retatrutide\"}],\"drugs_in_scope\":[],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"retatrutide\",\"name\":\"Retatrutide\",\"section_title\":\"Why Retatrutide might help you\",\"layer\":\"metabolic load / body weight\",\"steps\":[\"**What keeps failing:** Excess body weight multiplies compressive load on spine, hips, knees, and plantar fascia.\",\"**What Retatrutide is studied to do:** Studied for GLP-1/GIP/glucagon-driven weight loss — less mechanical load, not direct disc regeneration.\",\"**Therefore for you:** If that layer is part of your problem, Retatrutide is discussed because it targets repair (metabolic load / body weight) — not because it masks pain.\"],\"prose\":\"1. **What keeps failing:** Excess body weight multiplies compressive load on spine, hips, knees, and plantar fascia.\\n2. **What Retatrutide is studied to do:** Studied for GLP-1/GIP/glucagon-driven weight loss — less mechanical load, not direct disc regeneration.\\n3. **Therefore for you:** If that layer is part of your problem, Retatrutide is discussed because it targets repair (metabolic load / body weight) — not because it masks pain.\"}],\"drug_chains\":[","response":"{\"slug\":\"retatrutide-neuropathy\",\"title\":\"Retatrutide for Neuropathy: Evidence Review\",\"body\":\"## What's breaking down\\n\\nNeuropathy involves degeneration of peripheral nerves. Layers include metabolic stress from high blood sugar or excess weight, chronic low-grade inflammation, and impaired nerve repair signals. In diabetic cases, prolonged hyperglycemia damages small blood vessels that supply nerves, leading to sensory loss, pain, or tingling. Excess body weight adds indirect pressure through poorer circulation and higher systemic load on tissues. Repair pathways lag behind breakdown when metabolic control stays poor. Retatrutide is studied mainly for weight and glucose effects, not as a direct nerve regenerator.\\n\\n## Why Retatrutide might help you\\n\\n1. **What keeps failing:** Excess body weight multiplies compressive load on spine, hips, knees, and plantar fascia. This mechanical burden can worsen nerve compression or circulation issues in neuropathy.\\n2. **What Retatrutide is studied to do:** Studied for GLP-1/GIP/glucagon-driven weight loss — less mechanical load, not direct disc regeneration.\\n3. **Therefore for you:** If that layer is part of your problem, Retatrutide is discussed because it targets repair (metabolic load / body weight) — not because it masks pain.\\n\\nIf metabolic load contributes to your nerve symptoms through added tissue stress, reduced body weight could ease overall demand on nerves. This is an indirect pathway focused on lowering the breakdown rate rather than accelerating repair signals.\\n\\n## How these fit together\\n\\nSingle-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\\n- **Retatrutide** → metabolic load / body weight\\n\\n## What the evidence actually shows\\n\\nNo human trials test retatrutide specifically for neuropathy treatment (preclinical|mechanistic). Phase 2 and 3 trials (human) report dysesthesia as an adverse event in 2-20.9% of partic","tokens_in":15628,"tokens_out":3265,"cost":0,"prev":"genesis","hash":"7dc327c29408e3954a7c7eaff16d818a0059e2fbaffd65f86ff5522b0c238a98"},{"ts":"2026-07-17T02:41:18.907Z","model":"owner","action":"voxel_divide","prompt":"","input":"retatrutide-neuropathy","response":"22 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"7dc327c29408e3954a7c7eaff16d818a0059e2fbaffd65f86ff5522b0c238a98","hash":"679fb555d1846bca253dd2590e2f490b3a0a4e76657e674173c27485ca1f2647"}]}